Event Schedule
Don’t miss this opportunity to engage in transformative discussions and collaborations shaping the future of medicine
- Day 1
- Day 2
- Day 3
Don’t miss this opportunity to engage in transformative discussions and collaborations shaping the future of medicine
Early Registration ends on 21st June
We are thrilled to welcome you to the Summit on Pioneering Drug Delivery and Gene Therapy, hosted in the vibrant city of Valencia. Renowned for its perfect fusion of historic charm and avant-garde architecture, Valencia provides an inspiring setting for innovation and collaboration.
Explore groundbreaking advances in drug delivery and gene therapy while experiencing the city’s iconic landmarks, such as the futuristic City of Arts and Sciences and the picturesque old town. From its golden beaches to its renowned cuisine, Valencia offers the perfect environment for networking and discovery.
Join us at NanoThera 2025 to connect with global leaders and shape the future of healthcare innovation. We look forward to welcoming you!
Dra. María J. Vicent is a leading Spanish chemist and nanomedicine researcher, known for her work on polymer-based drug delivery systems for cancer and inflammatory diseases. She heads the Polymer Therapeutics Lab at the Centro de Investigación Príncipe Felipe (CIPF) in Valencia, where her pioneering research enhances drug efficacy and minimizes side effects. Widely published and respected, Dr. Vicent has made significant contributions to translating polymer therapeutics from research to clinical applications, and she actively supports interdisciplinary collaboration and women in science.
Dr. Pierre-Alexandre Driguez is specialized both in Carbohydrate and Lipid Chemistry. He holds a strategic position at Sanofi as Head of mRNA platform in Paris. His work is focused on the development of innovative Non-Viral vectors for Cell and Gene Therapy projects. Known for bridging fundamental science with clinical application, Dr. Driguez’s interdisciplinary work continues to drive forward the field of genetic medicine and therapeutic innovation.
Dr. Julen Oyarzabal is a prominent figure in drug discovery and chemical biology, particularly in oncology and precision medicine (>100 peer-reviewed scientific articles & >30 Patents). He serves as CSO for Syngoi, a biotechnology company specializing in synthetic genomics and gene synthesis, where he contributes to the development of advanced platforms for gene and cell therapies. Dr. Oyarzabal is also Partner and CSO at Columbus Venture Partners, where he helps identify and support cutting-edge biotech startups focused on innovative therapeutic solutions. His work across these roles emphasizes small-molecule drug development, targeted cancer therapies, and gene synthesis technologies, driving forward personalized medicine and novel treatment options.
Join us at the NanoThera Summit in the stunning city of Valencia. This is your opportunity to connect with global leaders, explore cutting-edge advances, and shape the future of healthcare innovation.
Set against Valencia’s inspiring blend of history, culture, and modernity, NanoThera 2025 promises not only unparalleled scientific discussions but also a chance to experience one of Europe’s most captivating cities.
Secure your place now and be part of the transformation in drug delivery and gene therapy. Register today!
Faculty members, seize this opportunity to engage with global leaders, share your expertise, and explore groundbreaking advances in drug delivery and gene therapy.
€350
€700
The Nanothera Summit 2025 offers industries a unique opportunity to showcase innovations, network, and explore potential collaborations in drug delivery and gene therapy.
€700
€1300
Students will have a unique opportunity at the Nanothera Summit 2025 to explore the latest innovations in drug delivery and gene therapy, while learning and networking with industry leaders.
€150
€350
NanoThera 2025, to be held in Valencia, will bring together international experts in nanotechnology and therapeutic biotechnology to discuss the latest advances in drug delivery, gene therapies, and nanoparticle development.
The conference will cover essential topics such as polymer design and functionalization, non-viral gene therapies, and GMP quality standards, all focused on translating these innovations into clinical applications. With an emphasis on collaboration and knowledge exchange, NanoThera will be a key opportunity for researchers, developers, and industry leaders to drive forward new therapeutic solutions and explore the frontiers of future medicine.
Welcome to the NanoThera Summit 2025, an International Symposium to be held in Valencia. This event provides a platform for world-renowned scientists to present their latest research and share their vision for the future of drug delivery and gene therapy, fostering interdisciplinary collaboration at the intersection of biology, chemistry, pharmaceutical sciences, and medicine.
This global forum in Valencia will be a focal point for cutting-edge developments set to shape the future of medicine.
Our FAQ section covers everything you need to know, from event details and registration to sponsorship opportunities and attendee benefits. Discover why NanoThera is the go-to summit for the latest in gene therapy and nanomedicine advancements.
